 "Eye-Q Super Specialty raises Rs 60 cr from IFC, Helion and Nexus")
Eye-Q Super Specialty Eye Hospitals, a chain of super-speciality hospitals providing quality standardised eye care, has received an investment of Rs 34 crores from IFC, a member of The World Bank Group. The investment is part of the Rs 60 crores financing raised by Eye-Q with current investors, Helion Venture Partners and Nexus Venture Partners.
Eye-Q has provided treatment to over 1 million patients till date and will use the funding to expand access to world class, high quality and affordable eye care treatments in India. Eye-Q has a unique combination of very experienced doctors and strong management team and plans to more than double its patient reach. Based on its approach and team, Eye-Q is the only eye care chain to be raise a large investment in last 18 months.
Rajat Goel, CEO and Co-Founder, Eye-Q Hospitals, said, “This investment by global investor like IFC and our current investors validates that we are amongst the best in class across the world andre-enforces our strategy of providing high quality treatment at affordable prices to the masses. We will use these funds to expand further by opening new centres and acquiring hospitals.”
With nearly 200 million people suffering from some form of vision problem in India, only a small portion of our people have access to high quality treatment. Eye-Q helps bridge this gap, improve the quality of patients’ lives and increase their productivity.
Dr Ajay Sharma, CMD and Founder, Eye-Q Super Specialty Eye Hospitals, added, “We already have best in class surgical outcomes and can now support more innovations to continue to deliver the best.”
“IFC’s investment in Eye-Q will help increase and improve access to affordable health services. Eye-Q’s focus on emerging cities will help expand access to quality eye-care services, while creating skilled healthcare jobs, especially for women,” said Pravan Malhotra, IFC’s venture capital lead for south and south east Asia. Around one-fourth of Eye-Q’s hospitals are already located in the low-income state of Uttar Pradesh.
Established in 2007, Eye-Q has emerged as the most preferred eye care chain of hospitals based on its patient care and use of advanced technology.
Eye-Q has provided treatment to over 1 million patients till date and will use the funding to expand access to world class, high quality and affordable eye care treatments in India. Eye-Q has a unique combination of very experienced doctors and strong management team and plans to more than double its patient reach. Based on its approach and team, Eye-Q is the only eye care chain to be raise a large investment in last 18 months.
Rajat Goel, CEO and Co-Founder, Eye-Q Hospitals, said, “This investment by global investor like IFC and our current investors validates that we are amongst the best in class across the world andre-enforces our strategy of providing high quality treatment at affordable prices to the masses. We will use these funds to expand further by opening new centres and acquiring hospitals.”
With nearly 200 million people suffering from some form of vision problem in India, only a small portion of our people have access to high quality treatment. Eye-Q helps bridge this gap, improve the quality of patients’ lives and increase their productivity.
Dr Ajay Sharma, CMD and Founder, Eye-Q Super Specialty Eye Hospitals, added, “We already have best in class surgical outcomes and can now support more innovations to continue to deliver the best.”
“IFC’s investment in Eye-Q will help increase and improve access to affordable health services. Eye-Q’s focus on emerging cities will help expand access to quality eye-care services, while creating skilled healthcare jobs, especially for women,” said Pravan Malhotra, IFC’s venture capital lead for south and south east Asia. Around one-fourth of Eye-Q’s hospitals are already located in the low-income state of Uttar Pradesh.
Established in 2007, Eye-Q has emerged as the most preferred eye care chain of hospitals based on its patient care and use of advanced technology.